Hunan Pharmaceutical Development Private Equity Fund Management
Overview
Hunan Pharmaceutical Development Private Equity Fund Management Co., Ltd. is a Chinese investment firm that manages private equity funds focused on the healthcare and pharmaceutical industries.
Portfolio Companies
1
Website
hnpdig.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Prisys Biotechnology Co., Ltd. | Nov 2020 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hunan Pharmaceutical Development Private Equity Fund Management based?
Hunan Pharmaceutical Development Private Equity Fund Management is headquartered in Changsha, China.
When was Hunan Pharmaceutical Development Private Equity Fund Management founded?
Founding year information for Hunan Pharmaceutical Development Private Equity Fund Management is not publicly available.
How many portfolio companies does Hunan Pharmaceutical Development Private Equity Fund Management have?
Hunan Pharmaceutical Development Private Equity Fund Management has 1 portfolio company in Caplight's dataset.
What are some companies in Hunan Pharmaceutical Development Private Equity Fund Management's portfolio?
Portfolio companies visible on Caplight include Prisys Biotechnology Co., Ltd..
What was Hunan Pharmaceutical Development Private Equity Fund Management's most recent investment shown here?
Hunan Pharmaceutical Development Private Equity Fund Management's most recent investment in this portfolio sample was in Prisys Biotechnology Co., Ltd. in 2020.
What sectors does Hunan Pharmaceutical Development Private Equity Fund Management focus on?
Hunan Pharmaceutical Development Private Equity Fund Management focuses on Healthcare & Life Sciences.
What company stages does Hunan Pharmaceutical Development Private Equity Fund Management focus on?
Hunan Pharmaceutical Development Private Equity Fund Management typically invests at the Mid stage.
What is Hunan Pharmaceutical Development Private Equity Fund Management's AUM?
Hunan Pharmaceutical Development Private Equity Fund Management's assets under management are estimated between $509.6M and $509.6M.